Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the effect of lipitor on the efficacy of otc drugs for seniors?What role does fiber rich food play in cholesterol management?Can fish oil reduce lipitor's effectiveness?Does lipitor interact with painkillers to reduce effectiveness?What are the long term effects of cosentyx's consistent efficacy?
What is the black box warning on Cipro? Cipro, a broad-spectrum antibiotic, has a black box warning due to its potential to cause serious side effects, particularly tendon rupture and tendonitis. This warning is based on the FDA's requirement that the label contain a boxed warning, the most serious warning the agency can issue [1]. What conditions increase the risk of tendon rupture? The risk of tendon rupture is higher in patients taking Cipro who also have risk factors such as: - Age over 60 years - Existing tendon problems or surgery - Musculoskeletal problems, such as rheumatoid arthritis or muscular dystrophy - Severe kidney problems - Taking certain medications, such as corticosteroids or NSAIDs [2] Can I continue taking Cipro if I experience tendon pain or swelling? No, if you experience tendon pain or swelling, you should stop taking Cipro immediately and consult your doctor [3]. They may recommend an alternative antibiotic or provide guidance on safely continuing treatment. What are the alternatives to Cipro for treating bacterial infections? For some bacterial infections, such as uncomplicated urinary tract infections, alternatives to Cipro may include azithromycin (Zithromax), doxycycline (Vibramycin), or levofloxacin (Levaquin). However, your doctor will determine the best alternative for your specific situation. [4] When was the black box warning added? The black box warning for tendon rupture associated with Cipro was added in 2008, after reports of tendon rupture and tendonitis increased [5]. Source [1] https://www.fda.gov/Drug%20Safety/Postmarket%20Drug%20Safety%20Information%20for%20Patients%20and%20Providers/ucm106216.htm https://www.drugpatentwatch.com/drugs/Ciprofloxacin https://www.accessdata.fda.gov/drugsatfda_docs/label2015/020126s035lbl.pdf https://www.drugs.com/cipro.html https://www.drugpatentwatch.com/news/fda-adds-black-box-warning-to-anti-inflammatory-ibuprofen/ The above information is accurate as of the given date but subject to change as drug regulation changes.
Other Questions About Black :